Reclaim
Device Ortho-Hip
PDI 10603295077503
General payments
$35,500,405
Research payments
$451,216
Through program year 2025, $35,500,405 in general payments and $451,216 in research payments were reported against Reclaim (Ortho-Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6,710,859 | 321 |
| 2025 | Research | $97,625 | 9 |
| 2024 | General | $4,991,338 | 295 |
| 2024 | Research | $139,325 | 19 |
| 2023 | General | $6,113,523 | 143 |
| 2023 | Research | $105,566 | 16 |
| 2022 | General | $7,082,924 | 254 |
| 2022 | Research | $108,550 | 17 |
| 2021 | General | $10,601,760 | 190 |
| 2021 | Research | $150 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,203 general · 62 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.